title: Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice.
authors.affiliation: Bayer Pharma AG, Berlin, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Brobert
authors.affiliation: Ceife - Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain.
authors.forename: Rodríguez L A
authors.initials: RL
authors.lastname: García
authors.affiliation: Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Garbe
authors.affiliation: Pharmo Institute for Drug Outcomes Research, Utrecht, The Netherlands.
authors.forename: I D
authors.initials: ID
authors.lastname: Bezemer
authors.affiliation: Drug Safety Research Unit, Southampton, UK.
authors.forename: D
authors.initials: D
authors.lastname: Layton
authors.affiliation: Friberg Research AB, Stockholm, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Friberg
authors.affiliation: Bayer Pharma AG, Berlin, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Suzart-Woischnik
authors.affiliation: Oxford PharmaGenesis™ Ltd, Oxford, UK.
authors.forename: J
authors.initials: J
authors.lastname: Alderson
authors.affiliation: Oxford PharmaGenesis™ Ltd, Oxford, UK.
authors.forename: C
authors.initials: C
authors.lastname: Winchester
authors.affiliation: Pharmo Institute for Drug Outcomes Research, Utrecht, The Netherlands.
authors.forename: R M C
authors.initials: RM
authors.lastname: Herings
authors.affiliation: Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Jobski
authors.affiliation: Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Schink
authors.affiliation: Drug Safety Research Unit, Southampton, UK.
authors.forename: S
authors.initials: S
authors.lastname: Shakir
authors.affiliation: Bayer Pharma AG, Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Soriano-Gabarró
authors.affiliation: Uppsala University, Uppsala, Sweden.
authors.forename: M A
authors.initials: MA
authors.lastname: Wallander